CTRI/2021/04/032552尚未招募不适用
A COMPARATIVE STUDY ON THE EFFECT OF ERANDA KSHAR YOGA AND TRYUSHNADI GUGGULU IN THE MANAGEMENT OF MEDOROGA W.S.R. TO DYSLIPIDEMIA
Ayurvedic and Unani Tibbia College and Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月4日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To evaluate the clinical efficacy of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.
研究概览
简要总结
Number of dyslipidemia patients are increasing in societies on analarming rate. Dyslipidemiais highly prevalent and is closely related to coronary heart disease which is the most commoncause of death. So a search for holistic and alternative intervention for treating early dyslipidemia is necessary which might not have side effects. This trial tries to search these quests.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •a) Patients between the age group of 18-60 years of either sex.
- •b) Willing and able to participate in the study for 90 days.
- •c) Patients having Serum Cholesterol 201-400mg/dl, Serum Triglycerides 151- 400 mg/dl LDL Cholesterol 131-250 mg/dl, HDL Cholesterol <40mg/dl.
- •d)Patients with strictly controlled Diabetes Mellitus (HbA1c less than or equal to 7%).
排除标准
- •Patients having medical history of- a)Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, congestive heart failure, Stroke or severe Arrhythmia, Unstable angina in the last six months.
- •b)Patients on prolonged (>6weeks) medication with corticosteroids, antidepressants, anticholinergics, immunosuppressant, estrogen replacement therapy etc.
- •or any other drugs that may have an influence on the outcome of the study and patients on oral contraceptives.
- •c)Patients with poorly controlled hypertension (systolic >140 and diastolic >90 mm of Hg) despite of antihypertensive agents.
- •d)Patients with evidence of malignancy.
- •e)Hypersensitivity to any of the trial drugs or their ingredients.
- •f)Patients who have completed participation in any other clinical trial drugs or their ingredients in one -month period.
- •g)Patients who have received any cholesterol lowering medication (allopathic drug) within last two weeks.
- •h)Pregnancy and Lactating mother.
结局指标
主要结局
To evaluate the clinical efficacy of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.
时间窗: 3 Months
次要结局
- To evaluate the safety of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.(90 Days)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
To evaluate the efficacy of eranda kshar yog and phaltrikadi yog in the management of medoroga w.r.t dyslipidemiaCTRI/2023/05/052340Ayurvedic and Unani Tibia College Hospital60
尚未招募
2 期
Udwartana followed by Virechana in Dyslipidemia, a Clinical StudyCTRI/2020/03/023890Dr Reeny Ravina Dias30
尚未招募
1 期
"Checking the Benefits of Bruhtyadi Vati in People with High Cholesterol (Dyslipidemia)"CTRI/2025/05/087052DrNileshkumar Samarjit Tiwari106
已完成
4 期
A Study on Postmarketing Xuezhikang Capsule for Treating DyslipidemiaDyslipidemiaNCT02057302China Academy of Chinese Medical Sciences2,400
已完成
不适用
Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian PopulationDyslipidemiasHouseholdsSurvey, Family LifeAtherosclerosisNCT03799185Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose13,610